Abstract:
A clamping apparatus for coupling an ultrasonic transducer to a conduit is disclosed. The clamping apparatus comprises a base portion fastened to the conduit and including a bracket for receiving an adapter. The adapter is attached to a housing and allows the housing to be rotated when the adapter is positioned in an upper portion of the bracket, and prevents the housing from being rotated when the adapter is positioned in a lower portion of the bracket. The housing is configured to enclose the ultrasonic transducer except for a housing opening along the bottom of the housing. The ultrasonic transducer extends through the housing opening and is spring biased against the conduit.
Abstract:
A system includes a container assembly comprising a cover threadingly coupled to a container along a threaded interface portion of an interface and a cover lock assembly. The cover lock assembly includes a lock screw configured to selectively move between a cover lock position and a cover release position. The lock screw extends across the interface to resist threaded rotation of the cover relative to the container in the cover lock position, and the lock screw is recessed away from the interface to enable threaded rotation of the cover relative to the container in the cover release position. The cover lock assembly also includes a lock insert configured to block movement of the lock screw from the cover lock position to the cover release position.
Abstract:
Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.
Abstract:
A clamping apparatus for coupling an ultrasonic transducer to a conduit is disclosed. The clamping apparatus comprises a base portion fastened to the conduit and including a bracket for receiving an adapter. The adapter is attached to a housing and allows the housing to be rotated when the adapter is positioned in an upper portion of the bracket, and prevents the housing from being rotated when the adapter is positioned in a lower portion of the bracket. The housing is configured to enclose the ultrasonic transducer except for a housing opening along the bottom of the housing. The ultrasonic transducer extends through the housing opening and is spring biased against the conduit.
Abstract:
Disclosed is a recombinant human insulin or analog conjugate thereof. Said conjugate is formed by connecting the ε-amino group of lysine 29 of the B chain to activated polyethylene glycol by means of an amide bond. Further disclosed is a method of preparing said conjugate, a pharmaceutical compound, and a use for said conjugate in preparing medication for treating Type 1 and Type 2 diabetes.
Abstract:
A chimeric protein containing neutrophil inhibitory factor and hirugen, the chimeric protein having an amino acid sequence that includes FPRPGSGG (SEQ ID NO:21) Also provided is a pharmaceutical composition comprising the chimeric protein, which can be used for treating or preventing cerebral injury and cerebral edema, or for inhibiting platelet aggregation.
Abstract translation:含有嗜中性粒细胞抑制因子和水蛭素的嵌合蛋白质,具有包含FPRPGSGG(SEQ ID NO:21)的氨基酸序列的嵌合蛋白质还提供了包含嵌合蛋白质的药物组合物,其可用于治疗或预防脑损伤, 脑水肿或抑制血小板聚集。
Abstract:
A circuit includes a tracking write circuit and a write circuit. Various write signals of the write circuit are generated based on tracking signals of the tracking write circuit. The write signals are used in a write operation of a memory cell.
Abstract:
Provided is a fusion protein, which comprises human fibroblast growth factor 21 and glucagon-like-peptide-1 or its analogs. Also provided is the medicament composition comprising the fusion protein, which can be used for treating or preventing obesity, diabetes, hyperglycemia and hyperlipidemia etc.
Abstract:
Provided is a chimeric protein comprising neutrophil inhibitory factor, the peptide FRRP specially recognizing the thrombin active site and hirugen. Also provided is a pharmaceutical composition comprising the chimeric protein, which can be used for treating or preventing cerebral injury and cerebral edema, inhibiting platelet aggregation etc.
Abstract:
The present application provides a rotary testing apparatus for use with a work piece. The rotary testing apparatus may include a rotor, a probe, and a lifting unit for maneuvering the probe about the work piece. The lifting unit may include a hydraulic lifting mechanism and a counterweight mechanism.